Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Puma Biotechnology Inc (PBYI)  
$5.02 0.14 (2.87%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 39,760,000
Market Cap: 199.60(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.23 - $7.4
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of products to enhance cancer care. Co. in-licenses from Pfizer, Inc., the global development and commercialization rights to PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357. Neratinib is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Co. is primarily focused on the development and commercialization of the oral version of neratinib, and its drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 111,405 323,302 559,647
Total Sell Value $0 $458,203 $1,175,528 $1,901,778
Total People Sold 0 6 11 11
Total Sell Transactions 0 7 19 58
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 300
  Page 5 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ludwig Jeffrey Jerome Chief Commercial Officer   •       •      –    2022-01-03 4 S $3.20 $15,121 D/D (4,727) 31,342 45%     
   Nougues Maximo F Chief Financial Officer   •       •      –    2022-01-03 4 S $3.19 $23,871 D/D (7,484) 59,791 45%     
   Hunt Douglas M See Remarks   •       •      –    2022-01-03 4 S $3.21 $11,890 D/D (3,707) 61,083 45%     
   Nougues Maximo F Chief Financial Officer   •       •      –    2021-12-02 4 S $2.95 $478 D/D (162) 67,275 5%     
   Hunt Douglas M See Remarks   •       •      –    2021-12-02 4 S $2.90 $1,279 D/D (441) 64,790 5%     
   Auerbach Alan H President and CEO   •       •       •   2021-12-02 4 S $2.90 $5,327 D/D (1,837) 4,412,300 5%     
   Wong Alvin F Chief Scientific Officer   •       •      –    2021-12-02 4 S $2.91 $3,294 D/D (1,131) 17,152 5%     
   Nougues Maximo F Chief Financial Officer   •       –      –    2021-11-02 4 S $5.67 $885 D/D (156) 67,437 52%     
   Hunt Douglas M See Remarks   •       –      –    2021-11-02 4 S $5.64 $2,409 D/D (427) 65,231 52%     
   Auerbach Alan H PRESIDENT AND CEO   •       •       •   2021-11-02 4 S $5.63 $10,112 D/D (1,795) 4,414,137 52%     
   Nougues Maximo F Chief Financial Officer   •       •      –    2021-10-04 4 S $6.20 $998 D/D (161) 67,593 66%     
   Hunt Douglas M See Remarks   •       •      –    2021-10-04 4 S $6.15 $2,726 D/D (443) 65,658 66%     
   Auerbach Alan H President and CEO   •       •       •   2021-10-04 4 S $6.15 $11,433 D/D (1,858) 4,415,932 66%     
   Hunt Douglas M See Remarks   •       –      –    2021-09-02 4 S $7.52 $3,174 D/D (422) 66,101 65%     
   Nougues Maximo F Chief Financial Officer   •       –      –    2021-09-02 4 S $7.51 $1,164 D/D (155) 67,754 65%     
   Auerbach Alan H PRESIDENT AND CEO   •       •       •   2021-09-02 4 S $7.60 $13,403 D/D (1,764) 4,417,790 65%     
   Nougues Maximo F Chief Financial Officer   •       –      –    2021-08-02 4 S $7.54 $1,161 D/D (154) 67,909 59%     
   Auerbach Alan H PRESIDENT AND CEO   •       •       •   2021-08-02 4 S $7.53 $13,286 D/D (1,764) 4,419,554 59%     
   Hunt Douglas M See Remarks   •       –      –    2021-08-02 4 S $7.53 $3,161 D/D (420) 66,523 59%     
   Nougues Maximo F Chief Financial Officer   •       –      –    2021-07-02 4 S $9.26 $1,435 D/D (155) 68,063 57%     
   Hunt Douglas M See Remarks   •       –      –    2021-07-02 4 S $9.15 $9,298 D/D (1,016) 66,943 57%     
   Auerbach Alan H PRESIDENT AND CEO   •       •       •   2021-07-02 4 S $8.84 $47,121 D/D (5,332) 4,421,318 57%     
   Wilson Troy Edward Director   –       •      –    2021-06-15 4 A $0.00 $0 D/D 27,858 28,208     -
   Miller Michael Patrick Director   –       •      –    2021-06-15 4 A $0.00 $0 D/D 27,858 78,511     -
   Moyes Jay M Director   –       •      –    2021-06-15 4 A $0.00 $0 D/D 27,858 34,180     -
  300 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us